tiprankstipranks
Alkem Laboratories Ltd. (IN:ALKEM)
:ALKEM
India Market
Want to see IN:ALKEM full AI Analyst Report?

Alkem Laboratories Ltd. (ALKEM) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

ALKEM Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Alkem
Laboratories Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALKEM Stock 12 Month Forecast

There Are No Analyst Ratings for IN:ALKEM In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ALKEM Financial Forecast

ALKEM Earnings Forecast

Next quarter’s earnings estimate for ALKEM is ₹41.60 with a range of ₹32.50 to ₹56.90. The previous quarter’s EPS was ₹53.19. ALKEM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ALKEM has Performed in-line its overall industry.
Next quarter’s earnings estimate for ALKEM is ₹41.60 with a range of ₹32.50 to ₹56.90. The previous quarter’s EPS was ₹53.19. ALKEM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ALKEM has Performed in-line its overall industry.

ALKEM Sales Forecast

Next quarter’s sales forecast for ALKEM is ₹35.42B with a range of ₹34.40B to ₹36.57B. The previous quarter’s sales results were ₹37.37B. ALKEM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ALKEM has Performed in-line its overall industry.
Next quarter’s sales forecast for ALKEM is ₹35.42B with a range of ₹34.40B to ₹36.57B. The previous quarter’s sales results were ₹37.37B. ALKEM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ALKEM has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on IN:ALKEM
Unknown Analyst
Jefferies
Not Ranked
Jefferies
₹6,550
Buy
17.84%
Upside
Reiterated
02/19/26
Jefferies Sticks to Their Buy Rating for Alkem Laboratories Ltd. (ALKEM)
J.P. Morgan Analyst forecast on IN:ALKEM
J.P. Morgan
J.P. Morgan
₹6,400
Hold
15.15%
Upside
Reiterated
11/13/25
HSBC
₹4,910₹4,850
Hold
-12.74%
Downside
Reiterated
10/14/25
HSBC Reaffirms Their Hold Rating on Alkem Laboratories Ltd. (ALKEM)
Nomura
₹5,430₹6,300
Buy
13.35%
Upside
Reiterated
08/22/25
Nomura Sticks to Their Buy Rating for Alkem Laboratories Ltd. (ALKEM)
Bank of America Securities Analyst forecast on IN:ALKEM
Bank of America Securities
Bank of America Securities
₹4,900₹5,530
Hold
-0.51%
Downside
Upgraded
08/13/25
Bank of America Securities upgrades Alkem Laboratories Ltd. (ALKEM) to a Hold
ICICI Securities Analyst forecast on IN:ALKEM
ICICI Securities
ICICI Securities
₹5,900₹6,065
Buy
9.12%
Upside
Upgraded
08/13/25
Positive Report for Alkem Laboratories Ltd. (ALKEM) from ICICI Securities
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on IN:ALKEM
Unknown Analyst
Jefferies
Not Ranked
Jefferies
₹6,550
Buy
17.84%
Upside
Reiterated
02/19/26
Jefferies Sticks to Their Buy Rating for Alkem Laboratories Ltd. (ALKEM)
J.P. Morgan Analyst forecast on IN:ALKEM
J.P. Morgan
J.P. Morgan
₹6,400
Hold
15.15%
Upside
Reiterated
11/13/25
HSBC
₹4,910₹4,850
Hold
-12.74%
Downside
Reiterated
10/14/25
HSBC Reaffirms Their Hold Rating on Alkem Laboratories Ltd. (ALKEM)
Nomura
₹5,430₹6,300
Buy
13.35%
Upside
Reiterated
08/22/25
Nomura Sticks to Their Buy Rating for Alkem Laboratories Ltd. (ALKEM)
Bank of America Securities Analyst forecast on IN:ALKEM
Bank of America Securities
Bank of America Securities
₹4,900₹5,530
Hold
-0.51%
Downside
Upgraded
08/13/25
Bank of America Securities upgrades Alkem Laboratories Ltd. (ALKEM) to a Hold
ICICI Securities Analyst forecast on IN:ALKEM
ICICI Securities
ICICI Securities
₹5,900₹6,065
Buy
9.12%
Upside
Upgraded
08/13/25
Positive Report for Alkem Laboratories Ltd. (ALKEM) from ICICI Securities
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alkem Laboratories Ltd.

3 Months
Success Rate
3/3 ratings generated profit
100%
Average Return
+7.77%
Copying Saion Mukherjee's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +7.77% per trade.
1 Year
Abdulkader PuranwalaICICI Securities
Success Rate
2/2 ratings generated profit
100%
Average Return
+12.35%
Copying Abdulkader Puranwala's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +12.35% per trade.
2 Years
Success Rate
3/3 ratings generated profit
100%
Average Return
+10.20%
Copying Saion Mukherjee's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +10.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALKEM Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
0
1
1
1
0
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
1
1
0
In the current month, ALKEM has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ALKEM average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

ALKEM Stock Forecast FAQ

What is IN:ALKEM’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:ALKEM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:ALKEM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Alkem Laboratories Ltd. a Buy, Sell or Hold?
      Currently, no data Available
      What is Alkem Laboratories Ltd.’s share price target?
      Currently, no data Available
      What do analysts say about Alkem Laboratories Ltd.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Alkem Laboratories Ltd.?
      To buy shares of IN:ALKEM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.